Breast Cancer
From the Journals
‘Unexpected’: Breast cancer spreads most during sleep
The findings carry potential implications for the timing of biopsy and treatment of metastasis-prone cancers, the authors say.
From the Journals
Good chemo vs. bad chemo: When too much is a bad thing
Study questions the use of inpatient chemotherapy pointing to negative outcomes and high mortality among some patients.
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Conference Coverage
This breast tumor subtype disproportionately affects Black women
HR-positive basal tumors are overrepresented in Black women and may be biologically similar to TNBC.
Conference Coverage
Metastatic lobular, ductal cancers respond similarly
Lobular cancers differ physiologically, but trial results generally apply to ductal tumors.
Conference Coverage
Survival for elderly breast cancer patients 25% after 4 years
The finding is based on an analysis of data between 2012 and 2016 from the SEER-Medicare database.
Conference Coverage
‘Large benefit’ in ovarian function suppression for breast cancer
Absolute gain for adding ovarian function suppression to tamoxifen increases with longer follow-up.
Conference Coverage
Neighborhood analysis links breast cancer outcomes to socioeconomic status
“This study should make clinicians cognizant of the potential for biases in management of metastatic breast cancer in terms of socioeconomic...
Conference Coverage
For cancer prevention, not all plant-based diets are equal
“The best plant-based diet for breast cancer prevention could be a healthy plant-based diet comprising fruit, vegetables, whole grains, nuts, and...
Conference Coverage
Autoimmune disease linked to better late-stage breast cancer survival
Retrospective data hint at antitumor activity, but other explanations are possible
Conference Coverage
Breast cancer deaths take a big dip because of new medicines
Research model suggests a 58% overall mortality decline in 2019 from metastatic breast cancer.